Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67

Journal of Clinical Pathology

Volumn 39, Issue 9, 1986, Pages 977-980

  Gerdes, J ^a   Lelle, R J ^b   Pickartz, H ^a   Heidenreich, W ^c   Schwarting, R ^a   Kurtsiefer, L ^a   Stauch, G ^c   Stein, H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Institute of Pathology Hannover   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

BREAST; BREAST CANCER; BREAST CARCINOMA; BREAST TUMOR; CELL GROWTH; CELL PROLIFERATION; CYTOLOGY; ETIOLOGY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; BREAST DISEASES; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MITOSIS; PROGNOSIS;

EID: 0022519296     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.39.9.977     Document Type: Article

References (16)

1. Bloom, H.J.G.; Richardson, W.W. Histological grading and prognosis in breast cancer Br J Cancer 1957 10.1038/bjc.1957.43 11 359 3
2. Schiodt, T. Breast carcinomas-a histologic andprognostic study of 650 followed up cases 1966
3. Gerdes, J.; Schwab, U.; Lemke, H.; Stein, H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation Int J Cancer 1983 10.1002/ijc.2910310104 31 13
4. Gerdes, J.; Lemke, H.; Baisch, H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67 J Immunol 1984 133 1710
5. Gerdes, J.; Dallenbach, F.; Lennert, K. Growth fractions in malignant non-Hodgkin's Lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67 1984 2 365
6. Stein, H.; Gerdes, J.; Schwab, U. Identification of Hodgkin and Steinberg-Reed cells as a unique cell type derived from a newly-detected small cell population Int J Cancer 1982 10.1002/ijc.2910300411 30 445
7. Cordell, J.L.; Falini, B.; Erber, W.N. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes J Histochem Cytochem 1984 10.1177/32.2.6198355 32 219
8. Cutler, S.J.; Black, M.M.; Friedell, R.A. Prognostic factors in cancer of the female breast. II. Reproducibility of histopathologic classification Cancer 1966 10.1002/1097-0142(196601)19:1<75::AID-CNCR2820190108>3.0.CO;2-4 19 75
9. Stenquist, B.; Westmann-Naeser, S.; Vegelius, J. Analysis of reproducibility of subjective grading systems for carcinoma J Clin Pathol 1979 10.1136/jcp.32.10.979 32 979
10. Tubiana, M.; Pejovic, M.J.; Renaud, A. Kinetic parameters and the coure of disease in breast cancer Cancer 1981 10.1002/1097-0142(19810301)47:5<937::AID-CNCR2820470520>3.0.CO;2-6 47 937
11. Meyer, J.S.; Friedman, E.; McCrate, M.M.; Bauer, W.C. Prediction of early course of breast carcinoma by thymidine labelling Cancer 1983 10.1002/1097-0142(19830515)51:10<1879::AID-CNCR2820511021>3.0.CO;2-9 51 1879
12. Haag, D.; Goerttler, K.; Tschahargane The proliferative Index (PI) of human breast cancer as obtained by flow cytometry Path Res Pract 1984 10.1016/S0344-0338(84)80020-5 178 315
13. Meyer, J.S.; Hixon, B. Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices Cancer Res 1979 39 4042
14. Meyer, J.S.; Lee, J.Y. Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival Cancer Res 1980 40 1890
15. Charlson, M.E.; Feinstein, A.R. Rapid growth rate in breast cancer: a confounding variable in adjuvant-chemotherapy trials Lancet 1982 10.1016/S0140-6736(82)92410-2 i: 1343
16. Valeriote, F.; van Putten, L. Proliferation-dependant cytotoxicity of anticancer agents: a review Cancer Res 1975 35 2619